XNAS · Healthcare · Drug Manufacturers - General
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | -0.16 | -0.21 | -31.25% | $0 | ❌ Miss | -1.99% | -20.11% | — |
| 2026-05-14 | Q1 2026 | -0.21 | -0.31 | -47.62% | $0 | ❌ Miss | -2.02% | -15.13% | +0.21% |
| 2026-03-25 |
| Q4 2025 |
| -0.34 |
| -0.83 |
| -144.12% |
| $0 |
| ❌ Miss |
| -0.79% |
| -14.96% |
| -36.24% |
| 2025-11-14 | Q3 2025 | -0.38 | -1.12 | -194.74% | $0 | ❌ Miss | — | — | — |
| 2025-08-11 | Q2 2025 | -0.39 | -0.43 | -10.26% | $0 | ❌ Miss | +1.02% | +1.52% | +3.05% |
Showing last 5 quarters.